Home›People›Tomas Helikar
TH

Tomas Helikar

President/CEO at ImmuNovus.

Executive
Updated Nov 10, 2026·Latest SEC filing Jul 29, 2026·Suggest an edit

About Tomas Helikar

Tomas Helikar is a president/ceo at ImmuNovus.

Experience

This experience comes from Tomas Helikar's profile and from SEC filings. For roles taken from filings, the years are when the filings name Tomas Helikar in the role, so the role may have started earlier or lasted longer.

ImmuNovus, Inc. Current
President/CEO
Founder and CEO (2023 – Present)
2023 – Present · Denton, NE
Immune system modeling and simulation for drug developers, clinicians and individuals.
UNMC College of Public Health Current
Professor; Department of Pharmacology and Experimental Neuroscience (by courtesy)
2018 – Present
University of Nebraska-Lincoln Current
Eberhard Professor
2013 – Present
Discovery Collective Current
Founder
2012 – Present
Global Outreach Program
Nebraska Core Group Member
2010 – 2018
SpiderFile Corp.
Founder & Sr. Consulting Partner
2006 – 2010
JooToo
Consultant
2001 – 2003

Sources

  1. SECImmuNovus, Inc. Form D, filed Jul 29, 2026